Search results for "survival analysi"

showing 10 items of 752 documents

Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?

2004

Abstract Introduction Increased concentrations of homocysteine (tHcy) are considered a potentially modifiable risk factor for coronary heart disease. The relationship between plasma homocysteine and prognosis has been less well studied. The aim of this study was to examine a possible relationship between the homocysteine levels in admission and all cause mortality in subjects presenting with non-ST segment elevation (NSTE) acute coronary syndrome. Methods We studied 854 patients with suspected NSTE acute coronary syndrome admitted consecutively to our institution, tHcy was determined at a median of 3 days from enrolment and was analyzed in tertiles together with classical risk factors and o…

Malemedicine.medical_specialtyAcute coronary syndromeHomocysteineMyocardial InfarctionCoronary Diseasechemistry.chemical_compoundInternal medicinemedicineClinical endpointHumansRisk factorHomocysteineAgedCreatinineAnalysis of Variancebiologybusiness.industryAcute-phase proteinmedicine.diseasePrognosisTroponinSurvival AnalysisSurgerychemistrySpainHeart failureCardiologybiology.proteinLinear ModelsFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersInternational journal of cardiology
researchProduct

Influence of Comorbid Conditions on One-Year Outcomes in Non–ST-Segment Elevation Acute Coronary Syndrome

2011

To investigate comorbid conditions with prognostic influence in non-ST-segment elevation acute coronary syndrome (NSTEACS).The study group consisted of a derivation cohort of 1017 patients (admitted from October 1, 2002, through October 1, 2008) and an external validation cohort of 652 patients (admitted from February 1, 2006, through September 30, 2009). Comorbid conditions, including risk factors and components of the Charlson comorbidity index (ChCI) and coronary artery disease-specific index, were recorded. The main outcome was one-year mortality.During follow-up, 103 patients died. After adjusting for variables associated with NSTEACS characteristics (base model), 5 comorbid conditions…

Malemedicine.medical_specialtyAcute coronary syndromeMyocardial InfarctionComorbidityRisk AssessmentCoronary artery diseaseVentricular Dysfunction LeftInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbusiness.industryST elevationMortality rateHazard ratioStroke VolumeGeneral MedicineMiddle Agedmedicine.diseasePrognosisComorbiditySurvival AnalysisConfidence intervalSurgeryMultivariate AnalysisCardiologyOriginal ArticleFemalebusiness
researchProduct

Combining Disability and Frailty in an Integrated Scale for Prognostic Assessment After Acute Coronary Syndrome

2018

Malemedicine.medical_specialtyAcute coronary syndromeScale (ratio)Risk AssessmentSeverity of Illness IndexCohort StudiesDisability EvaluationPredictive Value of TestsCause of DeathmedicineHumansHospital MortalityAcute Coronary SyndromeGeriatric AssessmentAgedAged 80 and overFrailtybusiness.industryGeneral MedicinePrognosismedicine.diseaseSurvival AnalysisHospitalizationSpainPhysical therapyFemalebusinessRevista Española de Cardiología (English Edition)
researchProduct

Outcome of extracorporeal membrane oxygenation support for high-risk percutaneous coronary intervention in non-ST-segment elevation acute coronary sy…

2020

Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentHemorrhageComorbidityRisk AssessmentSeverity of Illness IndexRussiaVentricular Dysfunction LeftText miningExtracorporeal Membrane OxygenationPercutaneous Coronary InterventionPostoperative Complicationscoronary intervention non-ST-segment elevation acute coronary syndromeInternal medicinemedicineExtracorporeal membrane oxygenationST segmentHumansNon-ST Elevated Myocardial InfarctionAgedbusiness.industryPatient SelectionPercutaneous coronary interventionGeneral Medicinemedicine.diseaseSurvival AnalysisOutcome and Process Assessment Health CareCoronary OcclusionCardiologyextracorporeal membrane oxygenation high-risk percutaneouFemaleRisk AdjustmentCardiology and Cardiovascular MedicinebusinessJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Hemoglobin, C-reactive protein and ferritin in patients with oral carcinoma and their clinical significance – A prospective clinical study

2017

For oral squamous cell carcinoma (OSCC), biomarkers are much in need to predict prognosis and to overcome possible resistance mechanisms to adjuvant therapies. The aim of this study was to evaluate serum level of hemoglobin, C-reactive protein (CRP) and ferritin as possible liquid biopsy to predict survival, metastasis and tumor relapse of OSCC.A prospective clinical study was conducted. Overall, serum levels of hemoglobin, CRP and ferritin in 82 OSCC patients and 63 controls were preoperatively investigated.Patients with an anemia showed a significant lower survival than patients with no anemia preoperative. Patients with T3/T4 cancer had significant lower hemoglobin values (p = 0.002). CR…

Malemedicine.medical_specialtyAnemiaGastroenterologyHemoglobins03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumormedicineCarcinomaHumansClinical significanceProspective StudiesLiquid biopsybiologybusiness.industryC-reactive protein030206 dentistryMiddle AgedPrognosismedicine.diseaseSurvival AnalysisHemoglobin CFerritinstomatognathic diseasesC-Reactive ProteinOtorhinolaryngologyCase-Control Studies030220 oncology & carcinogenesisFerritinsCarcinoma Squamous Cellbiology.proteinFemaleMouth NeoplasmsSurgeryHemoglobinOral SurgerybusinessJournal of Cranio-Maxillofacial Surgery
researchProduct

Phase II dose escalation study of caspofungin for invasive Aspergillosis.

2011

ABSTRACT Our objective was to evaluate the maximum tolerated dose of caspofungin for invasive aspergillosis (IA). The safety and pharmacokinetics of escalating dosages of caspofungin were investigated in IA. Eight patients each received caspofungin 70, 100, 150, or 200 mg once a day (QD). Dose-limiting toxicity (DLT) was defined as the same non-hematological treatment-related adverse event of grade ≥4 in 2 of 8 patients or ≥3 in 4 of 8 patients in a cohort. A total of 46 patients (median age, 61 years; 21 female; 89% with hematological malignancies) received caspofungin (9, 8, 9, and 20 patients in the 70-, 100-, 150-, and 200-mg cohorts) for a median of 24.5 days. Plasma pharmacokinetics w…

Malemedicine.medical_specialtyAntifungal AgentsDoseBiologyPharmacologyClinical TherapeuticsAspergillosisGastroenterologyDrug Administration ScheduleCohort Studieschemistry.chemical_compoundEchinocandinsLipopeptidesPharmacokineticsCaspofunginInternal medicinemedicineAspergillosisHumansPharmacology (medical)PharmacologyVoriconazoleVolume of distributionDose-Response Relationship DrugLiterMiddle Agedmedicine.diseaseSurvival AnalysisInfectious DiseasesTreatment OutcomechemistryToxicityFemaleCaspofunginmedicine.drugFollow-Up StudiesAntimicrobial agents and chemotherapy
researchProduct

Non-invasive peripheral vascular function, incident cardiovascular disease, and mortality in the general population

2021

AIMS Evidence suggests that peripheral vascular function is related to cardiovascular disease (CVD) and mortality. We evaluated the associations of noninvasive measures of flow-mediated dilatation and peripheral arterial tonometry with incident CVD and mortality. METHODS AND RESULTS In a post-hoc analysis of the community-based Gutenberg Health Study, median age 55 years (25th/75th percentile 46/65) and 49.5% women, we measured brachial artery flow-mediated dilatation (N = 12,599) and fingertip peripheral arterial tonometry (N = 11,125). After a follow-up of up to 11.7 years, we observed 595 incident CVD events, 106 cardiac deaths, and 860 deaths in total. Survival curves showed decreased e…

Malemedicine.medical_specialtyBrachial ArteryPhysiologyPopulation030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesVascular Stiffness0302 clinical medicineRisk FactorsPhysiology (medical)medicine.arteryInternal medicinemedicineHumans030212 general & internal medicineBrachial arteryeducationSurvival analysiseducation.field_of_studyProportional hazards modelbusiness.industryHazard ratioMiddle AgedConfidence intervalPeripheralCardiovascular DiseasesCohortCardiologyFemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessCardiovascular Research
researchProduct

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival esti…

2017

Abstract Background Cancer registries (CRs) are fundamental for estimating cancer burden, evaluating screening and monitoring health service performance. Stage at diagnosis—an essential information item collected by CRs—has been made available, for the first time, by CRs participating in EUROCARE-5. We analysed the quality of this information and estimated stage-specific survival across Europe for CRs with good data quality. Data and methods Sixty-two CRs sent stage (as TNM, condensed TNM or extent of disease) for 15 cancers diagnosed in 2000–2007. We assessed the quality, partly by comparing stage according to the three systems. We also developed procedures to reconstruct stage (categories…

Malemedicine.medical_specialtyCancer ResearchStage at diagnosiSurvivalConcordanceCancer registrieCancer registries ; Data quality ; Stage at diagnosis ; SurvivalSocio-culturaleReproducibility of ResultPredictive Value of TestCancer registries; Data quality; Stage at diagnosis; Survival; Data Accuracy; Europe; Female; Humans; Male; Neoplasm Metastasis; Neoplasms; Predictive Value of Tests; Reproducibility of Results; Survival Analysis; Neoplasm Staging; Registries; Oncology; Cancer Research03 medical and health sciences0302 clinical medicineBreast cancerPredictive Value of TestsNeoplasmsmedicineotorhinolaryngologic diseasesCancer registriesHumans030212 general & internal medicineRegistriesStage (cooking)Neoplasm MetastasisIntensive care medicineSurvival analysisCancer stagingNeoplasm Stagingbusiness.industryData qualityReproducibility of ResultsStage at diagnosismedicine.diseaseSurvival AnalysisCancer registryData AccuracyClinical trialNeoplasm MetastasiEuropeOncology030220 oncology & carcinogenesisData qualityNeoplasmFemaleSurvival AnalysibusinessHumanEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres

2013

Background & Aims Hepatitis C virus (HCV) is the leading aetiological factor of HCC in the western world where, overall, its incidence is increasing, despite data suggesting an initial drop in some areas. The aim of this study was to evaluate epidemiology, clinical features and survival of HCV-related HCC (HCV-HCC) in a wide time range in Italy. Methods Multicentre retrospective study including 3695 patients prospectively recruited by the ITA.LI.CA group. Patients were classified into three subgroups according to aetiology (Group A[GA], pure HCV; Group B[GB], HCV + cofactors; and Group C[GC], non-HCV) and in 5 time cohorts (5 years each), according to the year of diagnosis. Age, gender, Chi…

Malemedicine.medical_specialtyCarcinoma HepatocellularCirrhosisHepatitis C virushepatitis C hepatocellular carcinoma cirrhosismedicine.disease_causeGastroenterologyGroup BSex FactorsInternal medicineEpidemiologyPrevalencemedicineHumansHEPATOCELLULAR CARCINOMACIRRHOSISRetrospective StudiesHepatologybusiness.industryIncidenceLiver NeoplasmsAge FactorsRetrospective cohort studyHepatitis Cmedicine.diseaseHepatitis CSurvival Analysisdigestive system diseasesSurgeryItalyHepatocellular carcinomaEtiologyFemalebusinessLiver International
researchProduct

Selective Transarterial Chemoembolization of Advanced Hepatocellular Carcinomas: A Reasonable Palliative Option

2008

Abstract Background The purpose of this study was to provide information concerning the performance of selective transarterial chemoembolization (TACE) as a palliative treatment in patients with hepatocellular carcinoma (HCC), also in the case of multifocal lesions. Patients and methods We reviewed prospectively collected data on 43 patients with cirrhosis and HCC who underwent selective TACE as a palliative treatment. Patients were assigned to one of two groups: (1) those with one to three HCC lesions, and (2) those with four or more HCC lesions. Results One hundred and two TACE sessions were applied in 43 patients. There were 39 men and 4 women with a mean age of 65.5 ± 8.273 years. Alpha…

Malemedicine.medical_specialtyCarcinoma HepatocellularCirrhosismedicine.medical_treatmentGastroenterologyInternal medicinemedicineHumansIn patientEmbolizationChemoembolization TherapeuticAgedNeoplasm StagingRetrospective StudiesTransplantationAlpha fetoprotein levelsbusiness.industryLiver NeoplasmsPalliative CareAngiographyCancerMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryTransplantationHepatocellular carcinomaFemaleSurgeryalpha-FetoproteinsTomography X-Ray ComputedbusinessLiver cancerTransplantation Proceedings
researchProduct